News for Moderna Inc (0QF.BE)

The government’s target is to vaccinate every Canadian that wants a shot by the end of September.Pfizer vaccine was the first to be approved in Canada on Dec. 9 followed by Moderna Inc.’s vaccine which was licensed two weeks later on Dec. 23 and AstraZeneca Plc’s vaccine was authorized on Feb 26

The single-dose shot, which has been authorized for adults in Canada, was 66% effective at preventing moderate and severe disease, Supriya Sharma, a senior health ministry official, said at a briefing to announce the approval.

The U.S. death toll from the coronavirus-borne illness COVID-19 climbed above 520,000 on Friday, as Dr. Anthony Fauci became the latest health expert to slam...

Moderna, Inc. (NASDAQ: MRNA), which shot to prominence with its coronavirus vaccine program, is beefing up its research and development team. What ...

Canadian regulators have given the green light to Johnson & Johnson’s (NYSE:JNJ) COVID-19 vaccine.

Japanese Prime Minister Yoshihide Suga announced that his government is extending a state of emergency in the Tokyo region for another two weeks because its medical systems are still strained by COVID-19 patients.

With vaccinations lagging, Indonesia’s government has authorized private companies to acquire Covid-19 vaccines, but some public-health experts say the strategy will steer shots toward the middle-class and wealthy.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

Shares of Moderna Inc. undefined were down 0.9% in premarket trading on Friday after the company said it is pursuing approval for its COVID-19 vaccine in...

Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade ahead of the major jobs report. Analysts expect nonfarm payrolls rising ...

A botched deal last year between Canada and Chinese vaccine manufacturer CanSino Biologics Inc. laid bare this country’s vulnerabilities amid efforts to devise a proper immunization plan.

Moderna Inc. (NASDAQ: MRNA) and International Business Machines Corp. (NYSE: IBM) plan to collaborate on technologies that could help support smarter ...

JCR Pharmaceuticals Co said on Thursday it would build a new plant in Japan to expand production of ingredients for COVID-19 vaccines over the longer term. JCR Pharma along with Daiichi Sankyo Co and other Japanese partners are cooperating to produce and distribute the COVID-19 vaccine developed by AstraZeneca Plc…

The companies will focus on using technology to help governments and healthcare providers address potential supply chain disruptions through information sharing.

The Swiss drug company will make mRNA and other parts of CureVac’s two-dose vaccine, which is in late-stage testing with results expected as soon as next month.

By Sabrina Siddiqui and Tarini Parti Merck & Co. will help produce Johnson & Johnson's single-dose Covid-19 vaccine, President Biden plans to announce Tuesday, as the administration... | March 2, 2021

Read more about J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators on Business Standard. (Reuters) - Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on

with mutations in the spike protein have been spreading globally and appear to cause?major changes in the way the virus acts, including enhanced transmissibility and possibly increased clinical...

The major U.S. index futures are currently pointing to a higher opening on Monday following the starkly mixed performance seen in the previous session. The upward momentum on Wall Street comes as optimism about coronavirus vaccine rollouts and the economic outlook have overshadowed recent concerns about an increase in treasury yields.